Table 1. Profiles and clinical parameters of patients.
| Parameter | IgAN group without TW tratment (n =30) | IgAN group before TW tratment (n =30) | IgAN group after TW tratment (n =30) | Chronic tonsillitis group (n = 30) | Healthy volunteer group (n = 20) | Normal value (reference) |
|---|---|---|---|---|---|---|
| Age (years) | 42.37 ± 14.1 | 48.36 ± 16.1 | 48.36 ± 16.1 | 36 ± 11.2 | 40.1 ± 12.14 | - |
| Gender (male/female) | 15/15 | 15/15 | 15/15 | 16/14 | 6/4 | - |
| Urinary protein (mg/day) | 0.155 ± 0.35 | 0.105 ± 0.65 | 0.10 ± 0.26 | N.D. | N.D. | 0–0.15 |
| Hematuria (/hpf) | 42.07 ± 33.54 | 33.07 ± 33.54 | 13.04 ± 14.60 | 0 | 0 | 0 |
| Serum creatinine (mg/dL) | 0.92 ± 0.28 | 0.82 ± 0.48 | 0.65 ± 0.22 | N.D. | N.D. | 0.47–0.79 |
| Uric acid (mg/dL) | 5.83 ± 1.22 | 5.46 ± 1.46 | 4.65 ± 1.32 | N.D. | N.D. | 2.4–5.6 |
| CRP (mg/dL) | 0.87 ± 0.94 | 0.46 ± 0.65 | 0.28 ± 0.4 | N.D. | N.D. | 0–0.24 |
| Serum complement (U/mL) | 47.68 ± 8.42 | 43.68 ± 6.23 | 30.15 ± 4.22 | N.D. | N.D. | 28–44 |
Note: values are the means ± SDs. hpf = high-power field; N.D. = no data